Electronic laboratory notebooks (ELNs) are one of the fastest growing technologies in the pharmaceutical industry. ELNs allow researchers to digitally record information from drug discovery through commercialization, replacing paper notebooks. They help manage data and accelerate the drug discovery process. While ELNs offer benefits over paper, some resistance remains among researchers accustomed to traditional methods. As implementation increases among major pharmaceutical companies, ELNs are predicted to become more mainstream.